Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 278

The DOI matches its Crossref record.

LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER

YANG, RONALD M., NAITOH, JOHN, MURPHY, MICHAEL, WANG, HE-JING, PHILLIPSON, JULIA, DEKERNION, JEAN B., LODA, MASSIMO, REITER, ROBERT E. · 1998 · Journal of Urology

Abstract

No AccessJournal of UrologyClinical Urology: Original Articles1 Mar 1998LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER RONALD M. YANG, JOHN NAITOH, MICHAEL MURPHY, HE-JING WANG, JULIA PHILLIPSON, JEAN B. DEKERNION, MASSIMO LODA, and ROBERT E. REITER RONALD M. YANGRONALD M. YANG More articles by this author , JOHN NAITOHJOHN NAITOH More articles by this author , MICHAEL MURPHYMICHAEL MURPHY More articles by this author , HE-JING WANGHE-JING WANG More articles by this author , JULIA PHILLIPSONJULIA PHILLIPSON More articles by this author , JEAN B. DEKERNIONJEAN B. DEKERNION More articles by this author , MASSIMO LODAMASSIMO LODA More articles by this author , and ROBERT E. REITERROBERT E. REITER More articles by this author View All Author Informationhttps://doi.org/10.1016/S0022-5347(01)63776-5AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: p27 is an inhibitor of the cell cycle with potential tumor suppressor function. Decreased levels of p27 protein expression have been correlated with poor prognosis in patients with breast and colorectal carcinomas. Although as many as a third of patients with clinically localized prostate cancer will have relapse after radical prostatectomy, predicting who will have recurrence remains enigmatic. We examined the ability of p27 protein levels to predict outcome in patients with clinically localized disease who underwent radical prostatectomy. Materials and Methods: p27 protein expression was evaluated in 86 patients with clinical stage T1-2 prostate cancer who were treated with radical prostatectomy. Archived paraffin embedded specimens were sectioned and immunostained with p27 antibody, and scored by 2 independent observers in a blinded fashion. The absence or presence of p27 protein was then correlated with biochemical relapse in univariate and multivariate analyses. Results: In a multivariate analysis that included age, preoperative prostate specific antigen, Gleason score and pathological stage p27 was a strong independent predictor of disease-free survival (p = 0.0184, risk ratio 3.04), second only to pathological stage (p = 0.0001, risk ratio 6.73). Even more strikingly, multivariate analysis demonstrated that p27 was the strongest predictor of biochemical recurrence (p = 0.0081, risk ratio 4.99) among factors studied in patients with pathological T2a-T3b disease. Conclusions: Absent or low levels of p27 protein expression appear to be an adverse prognostic factor in patients with clinically organ confined disease treated by radical prostatectomy. This marker appears to be especially useful in those patients in whom surgery is believed to be potentially curative, that is patients with pathological T2-T3b disease. Patients with low or absent p27 protein expression may be candidates for novel adjuvant therapies. References 1 : Human cyclin E, a new cyclin that interacts with two members of the CDC2 gene family. Cell1991; 66: 1217. Google Scholar 2 : Association of human cyclin E with a periodic G1-S phase protein kinase. Science1992; 257: 1958. Google Scholar 3 : p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Gene Dev.1994; 8: 9. Google Scholar 4 : Mutational analysis of the human-cyclin dependent kinase inhibitor p27Kip1 in primary breast carcinomas. Hum. Genet.1996; 97: 91. Google Scholar 5 : Requirement of p27Kip1 for restriction point control of the fibroblast cell cycle. Science1996; 272: 877. Crossref, Medline, Google Scholar 6 : Impact of the cyclin-dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents. Nat. Med.1996; 2: 1204. Google Scholar 7 : Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer. Nat. Med.1997; 3: 227. Google Scholar 8 : Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlates with survival in young breast cancer patients. Nat. Med.1997; 3: 222. Google Scholar 9 : Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nat. Med.1997; 3: 231. Google Scholar 10 : p27 expression and gastric carcinoma. Nat. Med.1997; 3: 593. Google Scholar 11 : Adenocarcinoma of the prostate invading the seminal vesicle: definition and relation of tumor volume, grade and margins of resection to prognosis. J. Urol.1993; 149: 1040. Link, Google Scholar 12 : 5-year tumor recurrence rates after anatomical radical retropubic prostatectomy for prostate cancer. J. Urol.1994; 152: 1837. Link, Google Scholar 13 : Stage T1-2 Prostate Cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy. Int. J. Rad. Oncol., Biol. Phys.1997; 37: 1043. Google Scholar 14 : Risk factors for progression in patients with prostate cancer trea

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0022-5347(01)63776-5

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 278

Metadata

Authors
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E.
Venue
Journal of Urology
Published
1998-03
Volume
159
Issue
3
Pages
941-945
ISSN
  • 0022-5347 (ISSN-L)
  • 1527-3792
OpenAlex
W4301651270
Cited by
278
References
0
FWCI
31.08
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER. https://app.cochat.ai/papers/10.1016/s0022-5347(01)63776-5
The paper
YANG, R. M., NAITOH, J., MURPHY, M., WANG, H.-J., PHILLIPSON, J., DEKERNION, J. B., LODA, M., & REITER, R. E. (1998). LOW P27 EXPRESSION PREDICTS POOR DISEASE-FREE SURVIVAL IN PATIENTS WITH PROSTATE CANCER. Journal of Urology. https://doi.org/10.1016/s0022-5347(01)63776-5

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.